Humana Pharmacy Benefit Unit Sale Could Fetch up to $7B

Now watching

Next video starts in : 7 Play

Humana Pharmacy Benefit Unit Sale Could Fetch up to $7B

Humana Pharmacy Benefit Unit Sale Could Fetch up to $7B
Replay video
Up next

Michael Kors Hurts Luxury Goods Brands; Greece Deal Inches Forward

Unlock your personal NFL Now stream by signing in to NFL.com

Humana Pharmacy Benefit Unit Sale Could Fetch up to $7B

by TheStreet 2:37 mins

Humana Pharmacy Benefit Unit Sale Could Fetch up to $7B

by TheStreet 2:37 mins

Humana's management is exploring options for its pharmacy-benefit management business including an outright sale of the division, which some say could fetch as much as $7.1 billion. Humana's management, led by CEO Bruce Broussard, said in early May that it would consider alternatives for Humana Pharmacy Solutions. The unit is estimated to produce about $15.5 billion in revenue this year. Analysts say among the options being considered, are renegotiating pricing on generic drugs, outsourcing certain operations or selling the unit altogether. Likely buyers of the pharmacy benefits unit could include CVS Caremark (CVS), Express Scripts (ESRX) and Catamaran (CTRX).

TheStreet

Market Movers

  1. 2:24

    Hormel goes organic with Applegate

  2. 11:42

    Dollar/Fed in focus; Tiffany investors see green; Spam maker goes organic

  3. 1:22

    IRS tax return breach

  4. 3:25

    FIFA soccer corruption probe

  5. 1:32

    Tiffany shines; Michael Kors hits 52-week low; Hormel eyes high

  6. 12:02

    Bulls' long holiday; Time Warner Cable's new deal; Amazon takes on Etsy